Table 5. Characteristics of CKD-5 patients with PEW.
| No PEW | PEW | ||
| Sex, male/female | 14/12 | 6/5 | P = 0.969 |
| Age, y | 63 (54–73) | 62 (47–84) | P = 0.947 |
| Weight, kg | 68.0 (57–78) | 55 (51–77) | P = 0.122 |
| BMI, kg/m2 | 27.4 (23.0–30.0) | 21.8 (19.2–24.0) | P = 0.021* |
| Creatinine, µM | 589.5 (443.3–822.5) | 613.0 (407.0–683.0) | P = 0.921 |
| Urea, mM | 21.0 (17.0–27.8) | 18.5 (17.1–26.9) | P = 0.642 |
| Bicarbonates, mM | 24.5 (22.8–26.0) | 24.0 (22.0–25.0) | P = 0.393 |
| Proteins, g/L | 69.5 (66.8–76.3) | 64.0 (59–77.0) | P = 0.079 |
| Albumin, g/L | 36.0 (33.5–39.2) | 27.0 (26.0–33.1) | P = 0.001*** |
| Prealbumin, mg/L | 0.31 (0.28–0.39) | 0.22 (0.18–0.32) | P = 0.013* |
| Hemoglobin, g/L | 116.5 (103.5–123.3) | 116.0 (103.0–121.0) | P = 0.907 |
| Glucose, mM | 5.5 (4.8–6.6) | 5.4 (4.5–6.0) | P = 0.505 |
| Triacylglycerols, mM | 1.75 (1.29–1.56) | 1.45 (1.01–1.39) | P = 0.290 |
| HDL cholesterol, mM | 1.13 (0.86–1.32) | 1.04 (0.98–1.57) | P = 0.816 |
| LDL cholesterol, mM | 2.15 (1.69–3.59) | 1.76 (1.32–2.56) | P = 0.113 |
| CRP, mg/L | 3.2 (2.9–9.1) | 2.9 (2.9–12.0) | P = 0.912 |
| Anti diabetic therapy, % | 30.8 | 18.2 | P = 0.668 |
| Lipid-lowering therapy, % | 45.5 | 46.2 | P = 1.000 |
| RAA, % | 45.4 | 57.7 | P = 0.860 |
| Beta blocking agents, % | 45.4 | 42.3 | P = 1.000 |
Continuous data are expressed as median (interquartile range) and compared using Mann & Whitney U test. Categorical data are expressed as the frequency (%) and compared using Chi square test. Abbreviations: CKD, chronic kidney disease, CRP, C-reactive protein, BMI, body mass index, PEW, protein-energy wastng, RAA, renin angiotensin aldosterone.